We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blood Transfusions During Surgery Found Risky

By HospiMedica staff writers
Posted on 27 Nov 2007
Blood transfusions during surgery may triple the risk of suffering a heart attack or stroke, according to a new study.

Researchers from the Bristol Heart Institute at Bristol University (United Kingdom) examined the association between red blood cell transfusion and adverse outcomes in 8,500 cardiac surgery patients between April 1, 1996, and December 31, 2003. More...
Clinical, hematology, and blood transfusion databases were linked with the United Kingdom (UK) population register; additional hematocrit information was obtained from intensive care unit charts. Composite infection (respiratory or wound infection or septicemia) and ischemic outcomes (myocardial infarction, stroke, renal impairment, or failure) were pre-specified as coprimary end points. Secondary outcomes were resource use, cost, and survival.

The researchers found that patients who received a red blood cell transfusion during surgery experienced a three-fold increase in complications arising from lack of oxygen to key organs, such as in a heart attack or stroke. The risks associated with transfusion occurred regardless of hemoglobin levels, age, or health of the patient. This is a finding at odds with the widely held belief that red cell transfusion improves delivery of oxygen to tissues. The researchers also found that at any time after their operations, transfused patients were less likely to have been discharged from hospital, and were more likely to have died. The study was published in the November 27, 2007, issue of Circulation, the journal of the American Heart Association (AHA).

"This study demonstrates the cost implications of our current transfusion practice,” said lead author Gavin Murphy, M.D., Ph.D. "This is important, particularly in modern health systems where resources are finite, and should encourage the sort of research that will address the major health issues raised in the study.”

"This study shows the importance of putting such widespread beliefs to the test since it suggests that such transfusions may cause more problems than they solve,” said Professor Peter Weissberg, medical director of the British Heart Foundation (BHF, London, UK). "The results are a step towards making heart surgery even safer by flagging up an issue we can now address through research and improved transfusion guidelines.”


Related Links:
Bristol University
British Heart Foundation

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.